Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Design, synthesis and biological evaluation of novel 1,3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents.
Date
2018-04-06
Author
Inceler, Nazan
ÖZKAN, YEŞİM
Turan, Nilufer Nermin
Kahraman, Deniz Cansen
Atalay, Rengül
BAYTAŞ, Sultan
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
202
views
0
downloads
Cite This
With the aim of achieving new compounds possessing both anti-inflammatory and antiplatelet activities, we synthesized (E)-3-[3-(pyridin-3/4-yl)-1-(phenyl/sulfonylmethylphenyl)-1H-pyrazol-4-yl]acrylamides, and evaluated their COX-1 and COX-2 inhibitory and antiplatelet activities. Since COX-2 inhibitory and antiplatelet compounds have anticancer potential, we also screened their antiproliferative effects against three human cancer cell lines. Compounds 5n, 5p, 5s, 10d, 10g and 10i were determined as dual COX-2 inhibitor/antiplatelet compounds. Compound 10h appeared to be a compound that exhibited antiplatelet activity without inhibiting the COX enzyme. Compounds 5h, 10a and 10i were the most effective derivatives which displayed antiproliferative activity against Huh7, MCF7 and HCT116 cells. Particularly, compound 10i, as the compound exhibiting the highest cytotoxic, antiplatelet and COX-2 inhibitory activity, was remarkable.
Subject Keywords
Selective cox-2 inhibitors
,
Cardiovascular risk
,
Prostaglandin endoperoxides
,
Antiinflammatory activities
,
Breast-cancer
,
Derivatives
,
Thromboxane
,
Expression
,
Carcinoma
,
Prostacyclin
URI
https://hdl.handle.net/11511/32359
Journal
MedChemComm
DOI
https://doi.org/10.1039/c8md00022k
Collections
Graduate School of Informatics, Article
Suggestions
OpenMETU
Core
Design and synthesis of benzene-fused heterocycles: aminopyridazinones, chromenopyridinones and benzopyrazoloxazepines /
Keskin, Selbi; Balcı, Metin; Department of Chemistry (2015)
The interest in the synthesis of heterocyclic compounds has increased day by day due to their biological activities. This study focuses on the synthesis of different benzene-fused heterocycles. In the first part, we synthesized novel class of compounds, 4-aminophthalazin-1(2H)-ones starting from methyl 2-(2-methoxy-2-oxoethyl)-benzoate. Methylene group in this starting material was oxidized to the corresponding ketoester. Reaction of ketoesters with hydrazine derivatives provided the hydrazone derivatives. ...
Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells
Ibis, Kubra; Sinoplu, Esra; ÇALIŞKAN, BURCU; Kahraman, Deniz Cansen; Cetin-Atalay, Rengul; BANOĞLU, ERDEN (2021-10-01)
In our effort for the development of novel anticancer therapeutics, a series of isoxazole-piperazine analogues were prepared, and primarily screened for their antiproliferative potential against hepatocellular carcinoma (HCC; Huh7/Mahlavu) and breast (MCF-7) cancer cells. All compounds demonstrated potent to moderate cytotoxicity on all cell lines with IC50 values in the range of 0.09-11.7 mu M. Further biological studies with 6a and 13d in HCC cells have shown that both compounds induced G1 or G2/M arrests...
Studies on new synthetic methodologies for synthesis of phthalazinone derivatives vicyclization of 2-ethylnylbenzohydrazides
Yaman, Tolga; Doğan, Özdemir; Balcı, Metin; Department of Chemistry (2017)
Nitrogen-containing heterocyclic compounds display a wide range of biological activities, which account for the increasing interest for their synthesis. In particular, the pyridazinone and phthalazinone derivatives represent a privileged structural motif in biologically active natural products and pharmaceutical compounds. For example, 4-aminophthalizinones have shown potential as anticancer agents. We have developed a methodology for the synthesis of various substituted phthalazinone derivatives. The start...
TFA catalyzed sequential amination/annulation/aromatization reaction of 2-propynyl-1.3-dicarbonyl compounds with amines: A new one-pot approach to functionalized pyrroles
Demir, Ayhan Sıtkı; Aybey, Asuman; Kayalar, Metin (ARKAT USA, Inc., 2005-10-9)
Highly flexible and efficient syntheses of 1,2,3,5-substituted pyrroles starting from 2-propynyl1,3-dicarbonyl compounds and amines are presented. TFA catalyzed formation of the pyrroles is suggested to proceed through sequential amination of the carbonyl compounds followed by regioselective 5-exo-dig cyclization of the enaminone intermediate and aromatization.
Development of a synthetic methodology for thienopyridinone and thienodiazepinone derivatives and benzimidazo-oxazepines
Korkmaz Çokol, Nalan; Balcı, Metin; Department of Chemistry (2018)
Thienopyridinone and thienodiazepinone derivatives are known for their diverse pharmacological activities. Pyridinones and diazepinones play an important role in inhibition of some enzymes such as glycogen synthase kinase-3β and regulation of various cell functions. They also demonstrate an interesting property in the repair of damaged DNA. In the first part of this thesis, we synthesized thienopyridinone and thienodiazepinone derivatives. Aminothiophene derivatives were successfully synthesized via Gewald ...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
N. Inceler, Y. ÖZKAN, N. N. Turan, D. C. Kahraman, R. Atalay, and S. BAYTAŞ, “Design, synthesis and biological evaluation of novel 1,3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents.,”
MedChemComm
, pp. 795–811, 2018, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/32359.